MXPA04004604A - Proceso para la preparacion de imipenem cristalino. - Google Patents

Proceso para la preparacion de imipenem cristalino.

Info

Publication number
MXPA04004604A
MXPA04004604A MXPA04004604A MXPA04004604A MXPA04004604A MX PA04004604 A MXPA04004604 A MX PA04004604A MX PA04004604 A MXPA04004604 A MX PA04004604A MX PA04004604 A MXPA04004604 A MX PA04004604A MX PA04004604 A MXPA04004604 A MX PA04004604A
Authority
MX
Mexico
Prior art keywords
preparation
imipenem
crystalline imipenem
crystalline
high purity
Prior art date
Application number
MXPA04004604A
Other languages
English (en)
Inventor
Prakash Rai Bishwa
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of MXPA04004604A publication Critical patent/MXPA04004604A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se relaciona a un proceso para la preparacion de imipenem de alta pureza efectivo en costos e industrialmente ventajoso.
MXPA04004604A 2001-11-16 2002-11-18 Proceso para la preparacion de imipenem cristalino. MXPA04004604A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1152DE2001 2001-11-16
PCT/IB2002/004804 WO2003042215A1 (en) 2001-11-16 2002-11-18 Process for the preparation of crystalline imipenem

Publications (1)

Publication Number Publication Date
MXPA04004604A true MXPA04004604A (es) 2004-09-10

Family

ID=11097136

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04004604A MXPA04004604A (es) 2001-11-16 2002-11-18 Proceso para la preparacion de imipenem cristalino.

Country Status (15)

Country Link
US (1) US7332600B2 (es)
EP (1) EP1448563A1 (es)
JP (1) JP2005509037A (es)
KR (1) KR20050044506A (es)
CN (1) CN1608066A (es)
AR (1) AR037551A1 (es)
BR (1) BR0214209A (es)
CA (1) CA2467427A1 (es)
EA (1) EA200400682A1 (es)
HR (1) HRP20040552A2 (es)
HU (1) HUP0402112A2 (es)
MX (1) MXPA04004604A (es)
PL (1) PL368984A1 (es)
WO (1) WO2003042215A1 (es)
ZA (1) ZA200403961B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2447673A1 (en) * 2001-05-18 2002-11-28 Ranbaxy Laboratories Limited Process for the isolation of crystalline imipenem
JP2005023081A (ja) * 2003-06-11 2005-01-27 Api Corporation アルブチン結晶及びその製造方法
US7640048B2 (en) 2004-07-13 2009-12-29 Dexcom, Inc. Analyte sensor
EP1991110B1 (en) 2006-03-09 2018-11-07 DexCom, Inc. Systems and methods for processing analyte sensor data
EP4218548A1 (en) 2006-03-09 2023-08-02 Dexcom, Inc. Systems and methods for processing analyte sensor data
JP5220026B2 (ja) * 2006-12-15 2013-06-26 メルク・シャープ・アンド・ドーム・コーポレーション アルファ−ケトアミドの亜硫酸水素塩精製
US8621008B2 (en) 2007-04-26 2013-12-31 Mcafee, Inc. System, method and computer program product for performing an action based on an aspect of an electronic mail message thread
US8199965B1 (en) 2007-08-17 2012-06-12 Mcafee, Inc. System, method, and computer program product for preventing image-related data loss
US20130276061A1 (en) 2007-09-05 2013-10-17 Gopi Krishna Chebiyyam System, method, and computer program product for preventing access to data with respect to a data access attempt associated with a remote data sharing session
US8293924B2 (en) 2007-10-08 2012-10-23 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
US8893285B2 (en) 2008-03-14 2014-11-18 Mcafee, Inc. Securing data using integrated host-based data loss agent with encryption detection
US9077684B1 (en) 2008-08-06 2015-07-07 Mcafee, Inc. System, method, and computer program product for determining whether an electronic mail message is compliant with an etiquette policy
CN101891745B (zh) * 2010-07-20 2012-06-13 深圳市海滨制药有限公司 亚胺培南一水合物晶体的制备方法
CN101891744B (zh) * 2010-07-20 2012-06-13 深圳市海滨制药有限公司 亚胺培南一水合物结晶的制备方法
WO2012081033A2 (en) * 2010-12-06 2012-06-21 Sequent Scientific Limited A process for preparation of imipenem
CN103524508B (zh) * 2013-09-02 2016-03-30 上海龙翔生物医药开发有限公司 一种亚胺培南一水合物的结晶方法
CN113135916A (zh) * 2020-01-20 2021-07-20 鲁南制药集团股份有限公司 一种亚胺培南制备工艺的除钯方法
CN111747959B (zh) * 2020-05-15 2022-02-11 深圳市海滨制药有限公司 一种亚胺培南原料药的制备方法
CN114671877B (zh) * 2022-02-18 2023-05-16 珠海联邦制药股份有限公司 亚胺培南的精制方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE268240C (es)
JPS606957B2 (ja) * 1973-04-10 1985-02-21 ブリストル マイヤ−ズ カンパニ− 抗生物質誘導体の製造方法
US4194047A (en) * 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
DK153486C (da) * 1978-07-03 1988-11-28 Merck & Co Inc Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat
US4260543A (en) * 1978-07-03 1981-04-07 Merck & Co., Inc. Crystalline N-formimidoyl thienamycin
US4292436A (en) * 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
US5061730A (en) * 1987-01-26 1991-10-29 Fujisawa Pharmaceutical Co., Ltd. Carboxylic acid derivatives
DD268240A1 (de) * 1987-12-05 1989-05-24 Univ Schiller Jena Verfahren zur erzeugung von fuer die applikation in optiken aus polymeren werkstoffen geeigneten hochreinen 2-hydroxy-4-alkoxybenzophenonen
US5321020A (en) * 1989-03-28 1994-06-14 Pfizer Inc. Antibacterial 2-carbapenem derivatives
CA2023144A1 (en) * 1989-08-21 1991-02-22 Frank P. Dininno 2-(quinoliniumalkyl and isoquinoliniumalkyl)-phenyl carbapenem antibacterial agents
JPH03256262A (ja) 1990-03-07 1991-11-14 Nec Corp 磁気ディスク装置
US5240920A (en) * 1990-10-11 1993-08-31 Merck & Co., Inc. 2-(substituted-dibenzofuranyl and dibenzothienyl) carbapenem antibacterial agents
JPH06256262A (ja) * 1993-03-08 1994-09-13 Sekiyu Sangyo Kasseika Center ２，６−ナフタレンジカルボン酸ジメチルエステルの精製法
US5621084A (en) * 1994-04-05 1997-04-15 Pfizer Inc. Process for removal of allyl group or allyloxycarbonyl group
ATE187437T1 (de) * 1995-09-08 1999-12-15 Bracco Int Bv Verfahren zur kristallisierung aus wasser von (s)-n,n'-bis(2-hydroxy-1-(hydroxymethiel)ethyl> 5-((2-hydroxy-1-oxopropyl)amino>-2,4,6-triiodo- ,3- benzoldicarboxamide
DE69734779T2 (de) * 1996-03-14 2006-07-27 Novozymes A/S Erhöhte ausbeuten an einem kristallisierten protein unter verwenden eines festen adsorptionsmaterials
CN1109688C (zh) 1999-01-12 2003-05-28 中国药品生物制品检定所 他唑巴坦半水合物的制备与应用
JP2002540090A (ja) * 1999-03-22 2002-11-26 ピユラク・バイオケム・ベー・ブイ 乳酸を産業規模で精製する方法
GB9925215D0 (en) * 1999-10-26 1999-12-22 Cerestar Holding Bv Process for the manufacture of citric acid
CA2404703C (en) * 2000-03-31 2007-06-05 Shionogi & Co., Ltd. Novel crystal form of pyrrolidylthiocarbapenem derivative
IN191798B (es) 2000-11-03 2004-01-03 Ranbaxy Lab Ltd
AR035728A1 (es) * 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
CA2447673A1 (en) * 2001-05-18 2002-11-28 Ranbaxy Laboratories Limited Process for the isolation of crystalline imipenem
ES2368997T3 (es) * 2001-09-26 2011-11-24 Merck Sharp & Dohme Corp. Procedimiento de fabricación de compuestos de carbapenem.
USRE40794E1 (en) * 2001-09-26 2009-06-23 Merck & Co., Inc. Crystalline forms of carbapenem antibiotics and methods of preparation

Also Published As

Publication number Publication date
BR0214209A (pt) 2004-10-26
CN1608066A (zh) 2005-04-20
EA200400682A1 (ru) 2004-10-28
CA2467427A1 (en) 2003-05-22
KR20050044506A (ko) 2005-05-12
US20050004359A1 (en) 2005-01-06
US7332600B2 (en) 2008-02-19
HRP20040552A2 (en) 2004-10-31
ZA200403961B (en) 2005-09-19
HUP0402112A2 (hu) 2005-02-28
PL368984A1 (en) 2005-04-04
AR037551A1 (es) 2004-11-17
EP1448563A1 (en) 2004-08-25
JP2005509037A (ja) 2005-04-07
WO2003042215A1 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
MXPA04004604A (es) Proceso para la preparacion de imipenem cristalino.
YU42803A (sh) Novi kristalni oblici atorvastatin hemi-kalcijuma i postupci za njihovo pripremanje kao i novi postupci za pripremanje drugih oblika
EP1429757B8 (en) Crystalline forms of fluvastatin sodium
MXPA03003916A (es) Proceso para la preparacion de monohidrato de tienamicina de n-formimidoilo cristalino (monohidrato de imipenem).
MXPA03010548A (es) Proceso para el aislamiento de imipenem cristalino.
MXPA03010498A (es) Proceso para la preparacion de imipenem.
IL146811A0 (en) Novel method for preparing benzoperhydroisoindole compounds
AP2003002912A0 (en) Process for the preparation of amorphouse cilastatin sodium
GB9920959D0 (en) Novel process
WO2003007871A3 (en) Process for the preparation of acitretin
AU2003219423A1 (en) Process for the isolation of high purity crystalline citalopram base
MXPA05003881A (es) Preparacion de compuestos triazospiro.
WO2003007872A3 (en) Process for the preparation of citalopram hydrobromide
MY134151A (en) Process for the preparation of crystalline n-formimindoyl thienamycin monohydrate (imipenem monohydrate)
AU2002251423A1 (en) Process for the production of high purity iohexol
AU2002329208A1 (en) Process for the synthesis of high purity melamine
TW200420553A (en) Process for the synthesis of 3, 3a, 6, 6a-tetrahydro-2H-cyclopentan[b]furan-2-one
HU0001287D0 (en) New intermediate and process for its production
WO2002020490A3 (en) Process to produce halo-4-phenoxyquinolines
TW200505854A (en) Process for preparing high-purity hydroxyindolylglyoxylamides
IL152571A0 (en) A process for the preparation of high purity pemirolast
LT2004018A (en) Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
HUP9904727A3 (en) Process for production of high purity n-formylleucine
WO2002018364A3 (en) Process for preparing 2-phenyl-3-aminobenzothiophenes
AU2002340428A1 (en) Process for production of high purity tocopherols